Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,017
archived clinical trials in
Angina

Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
Capital Cardiology Associates
mi
from
Albany, NY
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
Capital Cardiology Associates
mi
from
Albany, NY
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
Fairfax Radiological Consultants
mi
from
Fairfax, VA
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
Fairfax Radiological Consultants
mi
from
Fairfax, VA
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
University of Montreal Medical Center
mi
from
Montreal,
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
University of Montreal Medical Center
mi
from
Montreal,
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
George Washington University School of Medicine
mi
from
Washington,
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
George Washington University School of Medicine
mi
from
Washington,
Click here to add this to my saved trials
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated:  12/31/1969
Long Beach Veterans Affairs
mi
from
Long Beach, CA
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTIONVI)
Status: Enrolling
Updated: 12/31/1969
Long Beach Veterans Affairs
mi
from
Long Beach, CA
Click here to add this to my saved trials
The Computed Tomography-derived Fractional Flow Reserve STAT Trial
Computed Tomography-derived Fractional Flow Reserve in the Systematic Triage of Emergency Department Acute Chest Pain Patients to Treatment. (The CTFFR-STAT Trial)
Status: Enrolling
Updated:  12/31/1969
Beaumont Health System - Royal Oak
mi
from
Royal Oak, MI
The Computed Tomography-derived Fractional Flow Reserve STAT Trial
Computed Tomography-derived Fractional Flow Reserve in the Systematic Triage of Emergency Department Acute Chest Pain Patients to Treatment. (The CTFFR-STAT Trial)
Status: Enrolling
Updated: 12/31/1969
Beaumont Health System - Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740
mi
from
Los Angeles, CA
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated:  12/31/1969
Providence Medical Group - Dayton Primary
mi
from
Dayton, OH
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated: 12/31/1969
Providence Medical Group - Dayton Primary
mi
from
Dayton, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Cardiology PC
mi
from
Birmingham, AL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Stanford university Hospital and Clinics
mi
from
Stanford, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center
mi
from
Jacksonville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institute Florida Hospital
mi
from
Orlando, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
The Medical Group of St. Joseph´s
mi
from
Atlanta, GA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
The Medical Group of St. Joseph´s
mi
from
Atlanta, GA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Northwestern University Med School
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Northwestern University Med School
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Caritas St. Elizabeth´s Medical Center
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Caritas St. Elizabeth´s Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Minneapolis Heart Institute
mi
from
Minneapolis, MN
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Cornell University
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Medical School
mi
from
Madison, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Medical School
mi
from
Madison, WI
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
Heart Care Associates
mi
from
Milwaukee, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Heart Care Associates
mi
from
Milwaukee, WI
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Internet Medical Group
mi
from
Rutherford, NJ
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Internet Medical Group
mi
from
Rutherford, NJ
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Triangle Primary Care
mi
from
Wake Forest, NC
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Triangle Primary Care
mi
from
Wake Forest, NC
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Comprehensive Physicians Associates
mi
from
Youngstown, OH
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Comprehensive Physicians Associates
mi
from
Youngstown, OH
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Northside Medical Center
mi
from
Youngstown, OH
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Northside Medical Center
mi
from
Youngstown, OH
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
J. Frank Martin, LLC
mi
from
Columbia, SC
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
J. Frank Martin, LLC
mi
from
Columbia, SC
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
South Carolina Internal Medicine Associates LLC
mi
from
Irmo, SC
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
South Carolina Internal Medicine Associates LLC
mi
from
Irmo, SC
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Colonial Family Practice
mi
from
Sumter, SC
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Colonial Family Practice
mi
from
Sumter, SC
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Bells Medical Clinic
mi
from
Bells, TX
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Bells Medical Clinic
mi
from
Bells, TX
Click here to add this to my saved trials
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated:  12/31/1969
Texas Familicare
mi
from
Hurst, TX
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Status: Enrolling
Updated: 12/31/1969
Texas Familicare
mi
from
Hurst, TX
Click here to add this to my saved trials
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: A Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: A Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain
Randomized Cost Comparison of Cardiac MRI Use in ED Patients With Chest Pain
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Baptist Medical Center - Emergency Department
mi
from
Winston-Salem, NC
Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain
Randomized Cost Comparison of Cardiac MRI Use in ED Patients With Chest Pain
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Baptist Medical Center - Emergency Department
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
UC Davis
mi
from
Sacramento, CA
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials